Womens Imaging

FES-PET could save $142M in breast cancer costs
By Will Morton
Adding F-18 fluroestradiol (FES)-PET/CT imaging to standard of care tests in women with suspected estrogen receptor (ER)-positive breast cancer could save millions.
May 20, 2024
Breast Mol
New guidance issued on PET/CT imaging in breast cancer
By Will Morton
The world’s top nuclear medicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma.
May 17, 2024
Breast Mol
Can positive leadership combat burnout among radiologists?
By Amerigo Allegretto
Implementing a positive leadership program can decrease burnout and the intention to leave among breast imaging staff.
May 15, 2024
Doctor Stress 400
ARRS: More chemo response details needed in breast MRI reporting
By Amerigo Allegretto
Several chemotherapy response characteristics are often left out of breast MRI reports.
May 15, 2024
Research presented at the ARRS annual meeting highlighted the need for more detailed breast MRI reporting for neoadjuvant chemotherapy responses. One finding highlighted was that BPE changes are underreported.
ARRS: ACR guideline changes lead to sharp uptick in breast MRI use
By Amerigo Allegretto
The use of breast MRI has increased 14-fold since the American College of Radiology (ACR) changed its guidelines in 2018.
May 13, 2024
Mri Scanner2 400
DBT may increase radiation exposure for women with breast implants
By Amerigo Allegretto
Including nonimplant-displaced views on DBT can lead to overall increased average glandular dosage for women with augmented breasts.
May 13, 2024
Breast Dbt Social
ARRS: DBT leads to less recalls among African American women
By Amerigo Allegretto
African American women are more likely to be recalled from a 2D digital mammography exam than from a digital breast tomosynthesis (DBT) exam.
May 8, 2024
Research presented at ARRS shows differences in recall rates for African American and Caucasian women who underwent DBT or 2D digital mammography.
ARRS: Dartmouth poster wins for CVD risk prediction potential using mammograms
By Liz Carey
A poster on cardiovascular disease (CVD) risk prediction using fat-enlarged axillary nodes on mammograms won a prestigious award at ARRS 2024.
May 6, 2024
Award-winning research: Screening mammograms showed variable lymph node morphology due to ectopic fat deposition in women with obesity. Image A (above) shows normal axillary lymph nodes measuring < 1.5 cm in 63-year-old woman with a body mass index (BM) = 43.2. Image B shows a possible fat-enlarged axillary node with large fatty hilum measuring 4.2 cm in a 52-year-old woman with a BMI = 45.8. Photo courtesy of American Roentgen Ray Society.
DBT + CEM boosts cancer detection in women with history of the disease
By Kate Madden Yee
Adding contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) increases early breast cancer detection in women with a history of the disease.
April 30, 2024
Breast Cancer3
USPSTF finalizes breast cancer screening recommendations
By Liz Carey
The USPSTF's final recommendations support breast cancer screening beginning at age 40, but don’t go as far as many screening advocates had hoped.
April 30, 2024
Mammogram Breast
Large language models underperform in breast imaging
By Amerigo Allegretto
Large language models such as ChatGPT and Google Gemini fall short in breast imaging.
April 30, 2024
Screenshot (1152)
U.S. federally qualified health centers show cancer screening gaps
By Kate Madden Yee
U.S. federally qualified health centers, intended to provide care to underserved populations across the country, show cancer screening gaps.
April 29, 2024
Breast Screening Mammo
Page 1 of 674
Next Page